Skip to content
Indigenous, Medical Health Aged Care

First Nations pharmacists awarded inaugural McMillan Grant

Pharmaceutical Society of Australia (PSA) 2 mins read

6 June 2023

The Pharmaceutical Society of Australia (PSA) today proudly announces three recipients of the inaugural PSA Faye McMillan Conference Grant, funding them to attend PSA’s National Conference, PSA23.

Professor Faye McMillan AM is a Wiradjuri yinaa (woman) originally from Trangie, NSW. She is a dedicated community pharmacist and is recognised as the first Indigenous Australian to hold a western degree in pharmacy in this country.

Inspired and supported by Professor McMillan herself, the PSA Faye McMillan Conference Grant will be to be awarded each year to an Aboriginal and/or Torres Strait Islander pharmacist to attend Australia’s leading pharmacist education conference hosted by PSA.

Professor McMillan and PSA are very pleased to announce that this year the grant will support three First Nations pharmacists to attend the PSA23 conference in Sydney from 28-30 July 2023.

The recipients of this year’s grant are -

Alexander Burke (NSW)

Attending this conference will allow me to network with leaders of the profession and to be a role model for young upcoming pharmacists especially those of First Nations background. I believe that the research that I am doing is of vital importance to share with my Australian pharmacy colleagues. My research focuses on how to train pharmacists to be more culturally safe with First Nations patients.

Kirra Natty (NSW)

As an intern I am wanting to broaden my horizons and get as much experience from different conferences and events as I can to see the full scope of pharmacy practice and the possibilities that are available.

Scott Bates (SA)

The PSA conference will be a great way to develop my skills and leadership in Aboriginal Health. Particularly attending the Deadly pharmacist panel. It would be a great opportunity to see what my pharmacy peers have done in this space and share back with the working group my learnings from the panel. Additionally, this could be an incredible resource for networking with likeminded pharmacists.

Quote attributable to PSA National President Dr Fei Sim FPS:

“All health professionals have an obligation to provide culturally safe and appropriate healthcare.”

“PSA acknowledges the ongoing need to increase participation of Aboriginal and Torres Strait Islander people in pharmacy, this grant opportunity represents a genuine commitment by PSA to support the existing pharmacist workforce who identify as Aboriginal and Torres Strait Islander people.”

“Congratulations to each recipient of the PSA Faye McMillian Conference Grant, we look forward to seeing Kirra, Scott and Alexander at PSA23!”

Quotes attributable to Prof. Faye McMillan:

“Creating spaces of belonging is a critical component for reconciliation in this country. Grant opportunities such as this allow us to hold this space for others to come into.”

“Yindyamarra (respect) to all the grant recipients and to PSA, Mandaang guwu (thank you).”


About us:

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.


Contact details:

Georgia Clarke   M: 0480 099 798  E: [email protected]

Media

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.